Metagenomi, Inc. (MGX)
(Delayed Data from NSDQ)
$4.08 USD
+0.31 (8.22%)
Updated Jun 28, 2024 04:00 PM ET
After-Market: $4.13 +0.05 (1.23%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth B Momentum D VGM
Balance Sheet
Fiscal Year End for Metagenomi, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 271 | 362 | 108 | -99,999 | -99,999 |
Receivables | 2 | 0 | 0 | NA | NA |
Notes Receivable | 0 | 0 | 0 | NA | NA |
Inventories | 0 | 0 | 0 | NA | NA |
Other Current Assets | 5 | 5 | 1 | NA | NA |
Total Current Assets | 278 | 367 | 109 | NA | NA |
Net Property & Equipment | 22 | 17 | 4 | NA | NA |
Investments & Advances | 11 | 8 | 6 | NA | NA |
Other Non-Current Assets | 0 | 0 | 0 | NA | NA |
Deferred Charges | 0 | 0 | 0 | NA | NA |
Intangibles | 0 | 0 | 0 | NA | NA |
Deposits & Other Assets | 11 | 7 | 5 | NA | NA |
Total Assets | 365 | 414 | 142 | NA | NA |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | NA | NA |
Accounts Payable | 2 | 2 | 1 | NA | NA |
Current Portion Long-Term Debt | 0 | 0 | 0 | NA | NA |
Current Portion Capital Leases | 0 | 0 | 0 | NA | NA |
Accrued Expenses | 11 | 9 | 4 | NA | NA |
Income Taxes Payable | 3 | 2 | 0 | NA | NA |
Other Current Liabilities | 49 | 35 | 20 | NA | NA |
Total Current Liabilities | 69 | 49 | 25 | NA | NA |
Mortgages | 0 | 0 | 0 | NA | NA |
Deferred Taxes/Income | 31 | 76 | 24 | NA | NA |
Convertible Debt | 0 | 0 | 30 | NA | NA |
Long-Term Debt | 0 | 0 | 0 | NA | NA |
Non-Current Capital Leases | 0 | 0 | 0 | NA | NA |
Other Non-Current Liabilities | 5 | 1 | 1 | NA | NA |
Minority Interest (Liabilities) | 0 | 0 | 0 | NA | NA |
Total Liabilities | 150 | 143 | 98 | NA | NA |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 351 | 346 | 77 | NA | NA |
Common Stock (Par) | 0 | 0 | 0 | NA | NA |
Capital Surplus | 0 | 0 | 0 | NA | NA |
Retained Earnings | -145 | -77 | -33 | NA | NA |
Other Equity | 9 | 2 | 1 | NA | NA |
Treasury Stock | 0 | 0 | 0 | NA | NA |
Total Shareholder's Equity | 215 | 272 | 44 | NA | NA |
Total Liabilities & Shareholder's Equity | 365 | 414 | 142 | NA | NA |
Total Common Equity | -136 | -74 | -33 | 0 | 0 |
Shares Outstanding | NA | NA | NA | NA | NA |
Book Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fiscal Year End for Metagenomi, Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 327 | 271 | -99,999 | -99,999 | 0 |
Receivables | 2 | 2 | NA | NA | 0 |
Notes Receivable | 0 | 0 | NA | NA | 0 |
Inventories | 0 | 0 | NA | NA | 0 |
Other Current Assets | 6 | 5 | NA | NA | 0 |
Total Current Assets | 336 | 278 | NA | NA | 0 |
Net Property & Equipment | 21 | 22 | NA | NA | 0 |
Investments & Advances | 11 | 11 | NA | NA | 0 |
Other Non-Current Assets | 0 | 0 | NA | NA | 0 |
Deferred Charges | 0 | 0 | NA | NA | 0 |
Intangibles | 0 | 0 | NA | NA | 0 |
Deposits & Other Assets | 6 | 11 | NA | NA | 0 |
Total Assets | 415 | 365 | NA | NA | 0 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | NA | NA | 0 |
Accounts Payable | 7 | 2 | NA | NA | 0 |
Current Portion Long-Term Debt | 0 | 0 | NA | NA | 0 |
Current Portion Capital Leases | 0 | 0 | NA | NA | 0 |
Accrued Expenses | 7 | 11 | NA | NA | 0 |
Income Taxes Payable | 3 | 3 | NA | NA | 0 |
Other Current Liabilities | 49 | 49 | NA | NA | 0 |
Total Current Liabilities | 71 | 69 | NA | NA | 0 |
Mortgages | 0 | 0 | NA | NA | 0 |
Deferred Taxes/Income | 20 | 31 | NA | NA | 0 |
Convertible Debt | 0 | 0 | NA | NA | 0 |
Long-Term Debt | 0 | 0 | NA | NA | 0 |
Non-Current Capital Leases | 0 | 0 | NA | NA | 0 |
Other Non-Current Liabilities | 5 | NA | NA | 0 | |
Minority Interest (Liabilities) | 0 | 0 | NA | NA | 0 |
Total Liabilities | 140 | 150 | NA | NA | 0 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 351 | NA | NA | 0 |
Common Stock (Par) | 0 | 0 | NA | NA | 0 |
Capital Surplus | 446 | 0 | NA | NA | 0 |
Retained Earnings | -170 | -145 | NA | NA | 0 |
Other Equity | 0 | 9 | NA | NA | 0 |
Treasury Stock | 0 | 0 | NA | NA | 0 |
Total Shareholder's Equity | 276 | 215 | NA | NA | 0 |
Total Liabilities & Shareholder's Equity | 415 | 365 | NA | NA | 0 |
Total Common Equity | 276 | -136 | 0 | 0 | 0 |
Shares Outstanding | 37.40 | NA | NA | NA | NA |
Book Value Per Share | 7.37 | 0.00 | 0.00 | 0.00 | 0.00 |